The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer

This publication has 21 references indexed in Scilit:

• Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: A retrospective study
  Radiotherapy and Oncology, 2006
• Cancer of the anal canal
  The Lancet Oncology, 2004
• Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.
  Journal of Clinical Oncology, 1997
• Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
  The Lancet, 1996
• Ten-year results of chemoradiation for anal cancer: Focus on late morbidity
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Improved outcome with escalated radiation dosing for anal carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C
  International Journal of Radiation Oncology*Biology*Physics, 1991